Pasar al contenido principal

MECANISMOS TRANSCRIPCIONALES DE PLASTICIDAD SINAPTICA EN CIRCUITOS DE MEMORIA EN UN MODELO MURINO DE NEURODEGENERACION

SAF2016-80027-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Sex differences in fear memory consolidation via Tac2 signaling in mice

  • Florido Torres, Antonio Luis
  • Velasco, Eric R.
  • Soto-Faguás, Carlos M.
  • Gómez-Gómez, Àlex
  • Pérez-Caballero, Laura
  • Molina, Patricia
  • Nadal, Roser
  • Pozo Mendoza, Óscar J., 1975-
  • Saura, Carlos A.
  • Andero, Raül
Memory formation is key for brain functioning. Uncovering the memory mechanisms is helping us to better understand neural processes in health and disease. Moreover, more specific treatments for fear-related disorders such as posttraumatic stress disorder and phobias may help to decrease their negative impact on mental health. In this line, the Tachykinin 2 (Tac2) pathway in the central amygdala (CeA) has been shown to be sufficient and necessary for the modulation of fear memory consolidation. CeA-Tac2 antagonism and its pharmacogenetic temporal inhibition impair fear memory in male mice. Surprisingly, we demonstrate here the opposite effect of Tac2 blockade on enhancing fear memory consolidation in females. Furthermore, we show that CeA-testosterone in males, CeA-estradiol in females and Akt/GSK3β/β-Catenin signaling both mediate the opposite-sex differential Tac2 pathway regulation of fear memory., We would also like to thank Noemí Haro for help with estradiol determination. Procedural images were created with BioRender.com. RA was supported by a NARSAD Young Investigator Grant #22434, Ramón y Cajal program RYC2014-15784, RETOS-MICINN SAF2016-76565-R FEDER funds, and ERANET-Neuron JTC 2019 ISCIII AC19/00077. CAS is supported by Ministerio de Ciencia e Inovación (MICINN) grant SAF2016-80027-R, PID2019-106615RB-100, and ISCIII (CIBERNED CB06/05/0042). RN was supported by MICINNgrant SAF2017-83430 and was a recipient of an ICREA Academia Award (Generalitat de Catalunya, 2015-2019). AF 2018 FI_B00030 and CMS 2017 FI_B00326 were recipients of Generalitat de Catalunya predoctoral fellowship. ERV was supported by BES-2017-080870 FPI-2017 fellowship from MINECO. LPC was supported by an FJC2018-037958-I (MCIyU). PM received support from FPU16/05416 (MCECD). OP was supported by the Spanish Health National System CPII16/00027.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sex differences in fear memory consolidation via Tac2 signaling in mice

  • Florido Torres, Antonio Luis
  • Velasco, Eric R.
  • Soto-Faguás, Carlos M.
  • Gómez-Gómez, Àlex
  • Pérez-Caballero, Laura
  • Molina, Patricia
  • Nadal, Roser
  • Pozo Mendoza, Óscar J., 1975-
  • Saura, Carlos A.
  • Andero, Raül
Memory formation is key for brain functioning. Uncovering the memory mechanisms is helping us to better understand neural processes in health and disease. Moreover, more specific treatments for fear-related disorders such as posttraumatic stress disorder and phobias may help to decrease their negative impact on mental health. In this line, the Tachykinin 2 (Tac2) pathway in the central amygdala (CeA) has been shown to be sufficient and necessary for the modulation of fear memory consolidation. CeA-Tac2 antagonism and its pharmacogenetic temporal inhibition impair fear memory in male mice. Surprisingly, we demonstrate here the opposite effect of Tac2 blockade on enhancing fear memory consolidation in females. Furthermore, we show that CeA-testosterone in males, CeA-estradiol in females and Akt/GSK3β/β-Catenin signaling both mediate the opposite-sex differential Tac2 pathway regulation of fear memory., We would also like to thank Noemí Haro for help with estradiol determination. Procedural images were created with BioRender.com. RA was supported by a NARSAD Young Investigator Grant #22434, Ramón y Cajal program RYC2014-15784, RETOS-MICINN SAF2016-76565-R FEDER funds, and ERANET-Neuron JTC 2019 ISCIII AC19/00077. CAS is supported by Ministerio de Ciencia e Inovación (MICINN) grant SAF2016-80027-R, PID2019-106615RB-100, and ISCIII (CIBERNED CB06/05/0042). RN was supported by MICINNgrant SAF2017-83430 and was a recipient of an ICREA Academia Award (Generalitat de Catalunya, 2015-2019). AF 2018 FI_B00030 and CMS 2017 FI_B00326 were recipients of Generalitat de Catalunya predoctoral fellowship. ERV was supported by BES-2017-080870 FPI-2017 fellowship from MINECO. LPC was supported by an FJC2018-037958-I (MCIyU). PM received support from FPU16/05416 (MCECD). OP was supported by the Spanish Health National System CPII16/00027.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Presenilin/γ-secretase-dependent epha3 processing mediates axon elongation through non-muscle myosin IIA

  • Javier, Miriam|||0000-0002-6437-2829
  • Marco, Sergi|||0000-0002-9747-0388
  • Rocandio, Daniel
  • Pons Vizcarra, Maria|||0000-0001-5008-5741
  • Janes, Peter W.
  • Lackmann, Martin
  • Egea, Joaquim
  • Saura Antolín, Carlos|||0000-0003-3692-5657
EphA/ephrin signaling regulates axon growth and guidance of neurons, but whether this process occurs also independently of ephrins is unclear. We show that presenilin-1 (PS1)/γ-secretase is required for axon growth in the developing mouse brain. PS1/γ-secretase mediates axon growth by inhibiting RhoA signaling and cleaving EphA3 independently of ligand to generate an intracellular domain (ICD) fragment that reverses axon defects in PS1/γ-secretase-and EphA3-deficient hippocampal neurons. Proteomic analysis revealed that EphA3 ICD binds to non-muscle myosin IIA (NMIIA) and increases its phosphorylation (Ser1943), which promotes NMIIA filament disassembly and cytoskeleton rearrangement. PS1/γ-secretase-deficient neurons show decreased phosphorylated NMIIA and NMIIA/actin colocalization. Moreover, pharmacological NMII inhibition reverses axon retraction in PS-deficient neurons suggesting that NMIIA mediates PS/EphA3-dependent axon elongation. In conclusion, PS/γ-secretase-dependent EphA3 cleavage mediates axon growth by regulating filament assembly through RhoA signaling and NMIIA, suggesting opposite roles of EphA3 on inhibiting (ligand-dependent) and promoting (receptor processing) axon growth in developing neurons.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

N -Methyl--Aspartate Receptor Link to the MAP Kinase Pathway in Cortical and Hippocampal Neurons and Microglia Is Dependent on Calcium Sensors and Is Blocked by α-Synuclein, Tau, and Phospho-Tau in Non-transgenic and Transgenic APP Mice

  • Franco, Rafael|||0000-0003-2549-4919
  • Aguinaga Andrés, David|||0000-0003-2506-7204
  • Reyes Resina, Irene|||0000-0003-2077-2537
  • Canela, Enric I.|||0000-0003-4992-7440
  • Lillo Jové, Jaume|||0000-0001-7712-0850
  • Tarutani, Airi|||0000-0003-3835-9070
  • Hasegawa, Masato
  • del Ser Badia, Anna|||0000-0003-1142-1989
  • del Rio, José A.
  • Kreutz, Michael R.
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Navarro Brugal, Gemma|||0000-0003-4654-0873
N -methyl--aspartate receptors (NMDARs) respond to glutamate to allow the influx of calcium ions and the signaling to the mitogen-activated protein kinase (MAPK) cascade. Both MAPK- and Ca 2+ -mediated events are important for both neurotransmission and neural cell function and fate. Using a heterologous expression system, we demonstrate that NMDAR may interact with the EF-hand calcium-binding proteins calmodulin, calneuron-1, and NCS1 but not with caldendrin. NMDARs were present in primary cultures of both neurons and microglia from cortex and hippocampus. Calmodulin in microglia, and calmodulin and NCS1 in neurons, are necessary for NMDA-induced MAP kinase pathway activation. Remarkably, signaling to the MAP kinase pathway was blunted in primary cultures of cortical and hippocampal neurons and microglia from wild-type animals by proteins involved in neurodegenerative diseases: α-synuclein, Tau, and p-Tau. A similar blockade by pathogenic proteins was found using samples from the APP transgenic Alzheimer's disease model. Interestingly, a very marked increase in NMDAR-NCS1 complexes was identified in neurons and a marked increase of both NMDAR-NCS1 and NMDAR-CaM complexes was identified in microglia from the transgenic mice. The results show that α-synuclein, Tau, and p-Tau disrupt the signaling of NMDAR to the MAPK pathway and that calcium sensors are important for NMDAR function both in neurons and microglia. Finally, it should be noted that the expression of receptor-calcium sensor complexes, specially those involving NCS1, is altered in neural cells from APP mouse embryos/pups.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Conventional and Non-Conventional Roles of Non-Muscle Myosin II-Actin in Neuronal Development and Degeneration

  • Javier, Miriam|||0000-0002-6437-2829
  • Saura Antolín, Carlos|||0000-0003-3692-5657
Myosins are motor proteins that use chemical energy to produce mechanical forces driving actin cytoskeletal dynamics. In the brain, the conventional non-muscle myosin II (NMII) regulates actin filament cytoskeletal assembly and contractile forces during structural remodeling of axons and dendrites, contributing to morphology, polarization, and migration of neurons during brain development. NMII isoforms also participate in neurotransmission and synaptic plasticity by driving actin cytoskeletal dynamics during synaptic vesicle release and retrieval, and formation, maturation, and remodeling of dendritic spines. NMIIs are expressed differentially in cerebral non-neuronal cells, such as microglia, astrocytes, and endothelial cells, wherein they play key functions in inflammation, myelination, and repair. Besides major efforts to understand the physiological functions and regulatory mechanisms of NMIIs in the nervous system, their contributions to brain pathologies are still largely unclear. Nonetheless, genetic mutations or deregulation of NMII and its regulatory effectors are linked to autism, schizophrenia, intellectual disability, and neurodegeneration, indicating non-conventional roles of NMIIs in cellular mechanisms underlying neurodevelopmental and neurodegenerative disorders. Here, we summarize the emerging biological roles of NMIIs in the brain, and discuss how actomyosin signaling contributes to dysfunction of neurons and glial cells in the context of., neurological disorders. This knowledge is relevant for a deep understanding of NMIIs on the pathogenesis and therapeutics of neuropsychiatric and neurodegenerative diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Neurotrophic properties of C-terminal domain of the heavy chain of tetanus toxin on motor neuron diseases

  • Herrando-Grabulosa, Mireia|||0000-0002-6685-3220
  • Aguilera, José|||0000-0002-9906-8034
  • Casas Louzao, Caty|||0000-0002-2273-6321
  • Talbot, Kevin|||0000-0001-5490-1697
The carboxyl-terminal domain of the heavy chain of tetanus toxin (Hc-TeTx) exerts a neuroprotective effect in neurodegenerative diseases via the activation of signaling pathways related to neurotrophins, and also through inhibiting apoptotic cell death. Here, we demonstrate that Hc-TeTx preserves motoneurons from chronic excitotoxicity in an in vitro model of amyotrophic lateral sclerosis. Furthermore, we found that PI3-K/Akt pathway, but not p21ras/MAPK pathway, is involved in their beneficial effects under chronic excitotoxicity. Moreover, we corroborate the capacity of the Hc-TeTx to be transported retrogradely into the spinal motor neurons and also its capacity to bind to the motoneuron-like cell line NSC-34. These findings suggest a possible therapeutic tool to improve motoneuron preservation in neurodegenerative diseases such as amyotrophic lateral sclerosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Adenosine A2A Receptor Antagonists Affects NMDA Glutamate Receptor Function. Potential to Address Neurodegeneration in Alzheimer's Disease

  • Franco, Rafael|||0000-0003-2549-4919
  • Rivas Santisteban, Rafael|||0000-0002-2078-6819
  • Casanovas, Mireia
  • Lillo, Alejandro
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Navarro Brugal, Gemma|||0000-0003-4654-0873
(1) Background. N-methyl d-aspartate (NMDA) ionotropic glutamate receptor (NMDAR), which is one of the main targets to combat Alzheimer's disease (AD), is expressed in both neurons and glial cells. The aim of this paper was to assess whether the adenosine A2A receptor (A2AR), which is a target in neurodegeneration, may affect NMDAR functionality. (2) Methods. Immuno-histo/cytochemical, biophysical, biochemical and signaling assays were performed in a heterologous cell expression system and in primary cultures of neurons and microglia (resting and activated) from control and the APPSw,Ind transgenic mice. (3) Results. On the one hand, NMDA and A2A receptors were able to physically interact forming complexes, mainly in microglia. Furthermore, the amount of complexes was markedly enhanced in activated microglia. On the other hand, the interaction resulted in a novel functional entity that displayed a cross-antagonism, that could be useful to prevent the exacerbation of NMDAR function by using A2AR antagonists. Interestingly, the amount of complexes was markedly higher in the hippocampal cells from the APPSw,Ind than from the control mice. In neurons, the number of complexes was lesser, probably due to NMDAR not interacting with the A2AR. However, the activation of the A2AR receptors resulted in higher NMDAR functionality in neurons, probably by indirect mechanisms. (4) Conclusions. A2AR antagonists such as istradefylline, which is already approved for Parkinson's disease (Nouriast® in Japan and Nourianz® in the US), have potential to afford neuroprotection in AD in a synergistic-like fashion. i.e., via both neurons and microglia.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Tissue Clearing and Expansion Methods for Imaging Brain Pathology in Neurodegeneration, From Circuits to Synapses and Beyond

  • Parra-Damas, Arnaldo|||0000-0001-5683-060X
  • Saura Antolín, Carlos|||0000-0003-3692-5657
Studying the structural alterations occurring during diseases of the nervous system requires imaging heterogeneous cell populations at the circuit, cellular and subcellular levels. Recent advancements in brain tissue clearing and expansion methods allow unprecedented detailed imaging of the nervous system through its entire scale, from circuits to synapses, including neurovascular and brain lymphatics elements. Here, we review the state-of-the-art of brain tissue clearing and expansion methods, mentioning their main advantages and limitations, and suggest their parallel implementation for circuits-to-synapses brain imaging using conventional (diffraction-limited) light microscopy -such as confocal, two-photon and light-sheet microscopy- to interrogate the cellular and molecular basis of neurodegenerative diseases. We discuss recent studies in which clearing and expansion methods have been successfully applied to study neuropathological processes in mouse models and postmortem human brain tissue. Volumetric imaging of cleared intact mouse brains and large human brain samples has allowed unbiased assessment of neuropathological hallmarks. In contrast, nanoscale imaging of expanded cells and brain tissue has been used to study the effect of protein aggregates on specific subcellular structures. Therefore, these approaches can be readily applied to study a wide range of brain processes and pathological mechanisms with cellular and subcellular resolution in a time- and cost-efficient manner. We consider that a broader implementation of these technologies is necessary to reveal the full landscape of cellular and molecular mechanisms underlying neurodegenerative diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice

  • Van der Jeugd, Ann|||0000-0003-0916-248X
  • Parra-Damas, Arnaldo|||0000-0001-5683-060X
  • Baeta Corral, Raquel
  • Soto Faguas, Carlos Manuel|||0000-0003-2954-4987
  • Ahmed, Tariq
  • LaFerla, Frank M.|||0000-0003-2324-6911
  • Gimenez-Llort, Lydia|||0000-0002-4091-489X
  • D'Hooge, Rudi
  • Saura Antolín, Carlos|||0000-0003-3692-5657
Accumulation of amyloid-β plaques and tau contribute to the pathogenesis of Alzheimer's disease (AD), but it is unclear whether targeting tau pathology by antioxidants independently of amyloid-β causes beneficial effects on memory and neuropsychiatric symptoms. Selenium, an essential antioxidant element reduced in the aging brain, prevents development of neuropathology in AD transgenic mice at early disease stages. The therapeutic potential of selenium for ameliorating or reversing neuropsychiatric and cognitive behavioral symptoms at late AD stages is largely unknown. Here, we evaluated the effects of chronic dietary sodium selenate supplementation for 4 months in female 3xTg-AD mice at 12-14 months of age. Chronic sodium selenate treatment efficiently reversed hippocampal-dependent learning and memory impairments, and behavior- and neuropsychiatric-like symptoms in old female 3xTg-AD mice. Selenium significantly decreased the number of aggregated tau-positive neurons and astrogliosis, without globally affecting amyloid plaques, in the hippocampus of 3xTg-AD mice. These results indicate that selenium treatment reverses AD-like memory and neuropsychiatric symptoms by a mechanism involving reduction of aggregated tau and/or reactive astrocytes but not amyloid pathology. These results suggest that sodium selenate could be part of a combined therapeutic approach for the treatment of memory and neuropsychiatric symptoms in advanced AD stages.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CRTC1 mediates preferential transcription at neuronal activity-regulated CRE/TATA promoters

  • Parra-Damas, Arnaldo|||0000-0001-5683-060X
  • Shen, Jie
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Rubió Ferrarons, Laura
Gene expression mediated by the transcription factor cAMP-responsive element-binding protein (CREB) is essential for a wide range of brain processes. The transcriptional coactivartor CREB-regulated transcription coactivator-1 (CRTC1) is required for efficient induction of CREB target genes during neuronal activity. However, the mechanisms regulating induction of specific CREB/CRTC1-dependent genes during neuronal activity remain largely unclear. Here, we investigated the molecular mechanisms regulating activity-dependent gene transcription upon activation of the CREB/CRTC1 signaling pathway in neurons. Depolarization and cAMP signals induce preferential transcription of activity-dependent genes containing promoters with proximal CRE/TATA sequences, such as c-fos, Dusp1, Nr4a1, Nr4a 2 and Ptgs2, but not genes with proximal CRE/TATA-less promoters (e.g. Nr4a 3, Presenilin-1 and Presenilin-2). Notably, biochemical and chromatin immunoprecipitation analyses reveal constitutive binding of CREB to target gene promoters in the absence of neuronal activity, whereas recruitment of CRTC1 to proximal CRE/TATA promoters depends on neuronal activity. Neuronal activity induces rapid CRTC1 dephosphorylation, nuclear translocation and binding to endogenous CREB. These results indicate that neuronal activity induces a preferential binding of CRTC1 to the transcriptional complex in CRE/TATA-containing promoters to engage activity-dependent transcription in neurons., UDBELLATERRA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex differences in fear memory consolidation via Tac2 signaling in mice

  • Florido Torres, Antonio Luis|||0000-0001-6184-0706
  • Velasco García, Eric Raúl|||0000-0002-8778-5618
  • Soto Faguas, Carlos Manuel|||0000-0003-2954-4987
  • Gomez-Gomez, A.|||0000-0001-8172-1827
  • Perez-Caballero, Laura|||0000-0002-2315-2213
  • Molina Molina, Patricia|||0000-0002-4118-4702
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
  • Pozo, Oscar J.|||0000-0002-1735-9728
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Andero Galí, Raül|||0000-0003-3641-8903
Memory formation is key for brain functioning. Uncovering the memory mechanisms is helping us to better understand neural processes in health and disease. Moreover, more specific treatments for fear-related disorders such as posttraumatic stress disorder and phobias may help to decrease their negative impact on mental health. In this line, the Tachykinin 2 (Tac2) pathway in the central amygdala (CeA) has been shown to be sufficient and necessary for the modulation of fear memory consolidation. CeA-Tac2 antagonism and its pharmacogenetic temporal inhibition impair fear memory in male mice. Surprisingly, we demonstrate here the opposite effect of Tac2 blockade on enhancing fear memory consolidation in females. Furthermore, we show that CeA-testosterone in males, CeA-estradiol in females and Akt/GSK3β/β-Catenin signaling both mediate the opposite-sex differential Tac2 pathway regulation of fear memory. The Tachykinin 2 (Tac2) pathway in the central amygdala is sufficient and necessary for modulating fear memory consolidation. The authors show that silencing Tac2 neurons in the amygdala of male mice reduces fear expression, while fear expression in female mice is increased when manipulations are made during proestrus.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interaction between a Novel Oligopeptide Fragment of the Human Neurotrophin Receptor TrkB Ectodomain D5 and the C-Terminal Fragment of Tetanus Neurotoxin

  • Candalija Iserte, Ana|||0000-0002-5003-3789
  • Scior, Thomas|||0000-0003-2196-2682
  • Rackwitz, Hans-Richard
  • Ruiz-Castelan, Jordan E.
  • Martinez-Laguna, Ygnacio
  • Aguilera, José|||0000-0002-9906-8034
This article presents experimental evidence and computed molecular models of a potential interaction between receptor domain D5 of TrkB with the carboxyl-terminal domain of tetanus neurotoxin (Hc-TeNT). Computational simulations of a novel small cyclic oligopeptide are designed, synthesized, and tested for possible tetanus neurotoxin-D5 interaction. A hot spot of this protein-protein interaction is identified in analogy to the hitherto known crystal structures of the complex between neurotrophin and D5. Hc-TeNT activates the neurotrophin receptors, as well as its downstream signaling pathways, inducing neuroprotection in different stress cellular models. Based on these premises, we propose the Trk receptor family as potential proteic affinity receptors for TeNT. In vitro, Hc-TeNT binds to a synthetic TrkB-derived peptide and acts similar to an agonist ligand for TrkB, resulting in phosphorylation of the receptor. These properties are weakened by the mutagenesis of three residues of the predicted interaction region in Hc-TeNT. It also competes with Brain-derived neurotrophic factor, a native binder to human TrkB, for the binding to neural membranes, and for uptake in TrkB-positive vesicles. In addition, both molecules are located together in vivo at neuromuscular junctions and in motor neurons.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Loss of presenilin function enhances tau phosphorylation and aggregation in mice

  • Soto Faguas, Carlos Manuel|||0000-0003-2954-4987
  • Sánchez Molina, Paula|||0000-0002-4124-5229
  • Saura Antolín, Carlos|||0000-0003-3692-5657
Mutations in the presenilin (PS/PSEN) genes encoding the catalytic components of γ-secretase accelerate amyloid-β (Aβ) and tau pathologies in familial Alzheimer's disease (AD). Although the mechanisms by which these mutations affect Aβ are well defined, the precise role PS/γ-secretase on tau pathology in neurodegeneration independently of Aβ is largely unclear. Here we report that neuronal PS deficiency in conditional knockout (cKO) mice results in age-dependent brain atrophy, inflammatory responses and accumulation of pathological tau in neurons and glial cells. Interestingly, genetic inactivation of presenilin 1 (PS1) or both PS genes in mutant human Tau transgenic mice exacerbates memory deficits by accelerating phosphorylation and aggregation of tau in excitatory neurons of vulnerable AD brain regions (e.g., hippocampus, cortex and amygdala). Remarkably, neurofilament (NF) light chain (NF-L) and phosphorylated NF are abnormally accumulated in the brain of Tau mice lacking PS. Synchrotron infrared microspectroscopy revealed aggregated and oligomeric β-sheet structures in amyloid plaque-free PS-deficient Tau mice. Hippocampal-dependent memory deficits are associated with synaptic tau accumulation and reduction of pre- and post-synaptic proteins in Tau mice. Thus, partial loss of PS/γ-secretase in neurons results in temporal- and spatial-dependent tau aggregation associated with memory deficits and neurodegeneration. Our findings show that tau phosphorylation and aggregation are key pathological processes that may underlie neurodegeneration caused by familial AD-linked PSEN mutations.